Tarle, Alfred .

HRN: 13-71-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
CEFTRIAXONE 1G (VIAL)
12/26/2024
01/02/2025
IV
1g
Q12
TBI; Lacerated Wound; Fracture
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft TissueCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: